- Report
- September 2021
- 40 Pages
China
From €2481EUR$2,600USD£2,079GBP
- Report
- April 2021
- 50 Pages
China
From €2481EUR$2,600USD£2,079GBP
- Report
- September 2019
- 30 Pages
China
From €2100EUR$2,200USD£1,759GBP
- Report
- February 2024
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- January 2024
- 182 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2022
- 216 Pages
Middle East
From €3293EUR$3,450USD£2,759GBP
- Report
- December 2021
- 191 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- December 2024
- 85 Pages
Spain
From €3340EUR$3,500USD£2,799GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Report
- February 2023
- 220 Pages
Global
From €7158EUR$7,500USD£5,997GBP
- Report
- February 2022
- 220 Pages
Global
From €9067EUR$9,500USD£7,597GBP
- Report
- August 2022
- 118 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2022
- 115 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2022
- 120 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2022
- 117 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2021
- 100 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- November 2023
- 140 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- August 2022
- 140 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Report
- March 2024
- 30 Pages
Global
From €2625EUR$2,750USD£2,199GBP
- Report
- March 2024
- 159 Pages
Global
From €7587EUR$7,950USD£6,357GBP

The anticoagulant market within the context of cardiovascular drugs is a rapidly growing sector of the pharmaceutical industry. Anticoagulants are drugs used to prevent the formation of blood clots, which can lead to serious medical conditions such as stroke and heart attack. These drugs are used to reduce the risk of thrombosis, a condition in which a blood clot forms in a blood vessel, blocking the flow of blood. Anticoagulants are also used to treat existing blood clots, as well as to prevent the formation of new ones.
The anticoagulant market is driven by the increasing prevalence of cardiovascular diseases, such as coronary artery disease, stroke, and peripheral artery disease. The rising demand for anticoagulants is also driven by the increasing aging population, as well as the increasing awareness of the importance of preventive healthcare.
Some of the major companies in the anticoagulant market include Bayer AG, Bristol-Myers Squibb, Pfizer, Sanofi, and Johnson & Johnson. These companies are engaged in the development, manufacture, and marketing of anticoagulant drugs. Show Less Read more